Physician Wealth Advisors’s Celanese CE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$489 Sell
11
-6
-35% -$274 ﹤0.01% 2263
2026
Q2
$782 Buy
+17
New +$984 ﹤0.01% 1921
2026
Q1
– Sell
-12
Closed -$508 – 2087
2025
Q4
$508 Buy
+12
New +$489 ﹤0.01% 1879
2025
Q1
– Sell
-10
Closed -$693 – 1452
2024
Q4
$693 Buy
+10
New +$961 ﹤0.01% 1041

Other funds holding CE

Physician Wealth Advisors's CE Position: Q3 2026 in Review

Physician Wealth Advisors reduced its Celanese (CE) stake by 35% in Q3 2026, selling an estimated $274 and leaving 11 shares worth $489. The position accounts for ﹤0.01% of the portfolio, ranked #2263.

Physician Wealth Advisors first reported a position in CE in Q4 2024 and has held it in 4 quarters since. The position peaked at $782 in Q2 2026. 252 funds tracked by Wall St. Rank hold CE as of Q3 2026.

  • Physician Wealth Advisors held 11 shares of Celanese worth $489 as of Q3 2026.
  • Physician Wealth Advisors sold 6 Celanese shares in Q3 2026, an estimated $274.
  • Celanese made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #2263 holding.
  • Physician Wealth Advisors first reported a position in Celanese in Q4 2024 and has held it in 4 quarters since.
  • Physician Wealth Advisors's Celanese position peaked at $782 in Q2 2026.
  • 252 funds tracked by Wall St. Rank held Celanese as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.